Efficacy of M. charantia Leaves in the Correction of Induced Diabetes.

Assou Cendra^{1, 2}, Anago Eugénie², Agbogba Félicienne^{1, 2}, Agniwo Privat², Abissi Yollande¹, Lokonon Jacques Ezéchiel¹, Tchogou Pascal¹, Houngbeme Alban³, Baba-Moussa Lamine⁴, Gbénou Joachim⁵ and Sènou Maximin^1,

¹Unité de Biologie Expérimentale et Clinique (LaBEC), Laboratoire de Biotechnologie Médicdale et Pharmaceutique (LaRBiMeP), Ecole Nationale Supérieure des Biosciences et Biotechnologie Appliquées de Dassa-Zoumé (ENSBBA), Université Nationale des Sciences, Technologies, Ingénierie et Mathématiques d’Abomey (UNSTIM), R Bénin.

²Laboratoire de Recherche en Biologie Appliquée (LARBA), École Polytechnique d’Abomey-Calavi (EPAC), Université d’Abomey-Calavi (UAC), R Bénin.

³Laboratoire National de Pharmacognosie/Centre Béninois de la Recherche Scientifique et Technique (CBRST). BP 06 Oganla Porto-Novo, R Bénin

⁴Laboratory of Biology and Molecular Typing in Microbiology, University of Abomey-Calavi 01 BP 188 Cotonou, R Benin

⁵Ecole doctorale (ED-STIM), Université Nationale des Sciences, Technologies, Ingénierie et Mathématiques (UNSTIM), R Bénin.

Cite this paper:
Assou Cendra, Anago Eugénie, Agbogba Félicienne, Agniwo Privat, Abissi Yollande, Lokonon Jacques Ezéchiel, Tchogou Pascal, Houngbeme Alban, Baba-Moussa Lamine, Gbénou Joachim and Sènou Maximin. Efficacy of M. charantia Leaves in the Correction of Induced Diabetes.. American Journal of Medical Sciences and Medicine. 2023; 11(3):74-79. doi: 10.12691/ajmsm-11-3-2

Abstract

Diabetes is a major public health problem, due to its high and growing prevalence on the one hand, and its socio-economic impact on the other. Correcting this disease relies on glycemic control, particularly through medication. The majority of African populations are attached to the use of traditional herbal treatments, due to the high cost of modern treatments. The aim of this study is to demonstrate the anti-hyperglycemic activity of M. Charantia leaf extract, its corrective effect on streptozotocin-induced pancreatic lesions and its anti-glucose activity.Phytochemical screening was carried out on the extract and on extraction by the maceration method. Diabetes was induced in rats by injection of five doses of streptozotocin (40 mg/kg) body weight. Efficacy in animals was tested by treating them with the extracts for 28 consecutive days at 10mg/L. Biochemical and hematological parameters were measured by spectrophotometer and hematology apparatus respectively. Histological studies were carried out by fixing pancreases with a 10% formalin solution and staining with hematoxylin-eosin (HE).Phytochemical analysis of the plant revealed that the leafy stem is very rich in secondary metabolites (9 groups). In the efficacy test, leaf extract reduced cholesterol levels, and regulated triglyceridemia and white blood cell count. Leaf extract restored islet lesions in the pancreas.

Keywords:
Diabetes Momordica charantia leaf African.

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	WHO. https://www.who.int/fr/news-room/fact-sheets/detail/diabetes.
[2]	Diop SN, Djrolo F, Traoré Sidibé A, et al. Consensus pour la prise en charge de l’hyperglycémie dans le diabète de type 2 en Afrique subsaharienne. Rédigé par un groupe d’experts africains du diabète. Médecine des Mal Métaboliques. 2019;13(2):210-216.
[3]	Djrolo F, Houinato D, Gbary A, Akoha R, Djigbénoudé O, Sègnon J. Prévalence du diabète sucré dans la population adulte à Cotonou, Bénin: Prevalence of diabetes mellitus in the adult population at Cotonou, Benin. Médecine des Mal Métaboliques. 2012;6(2):167-169.
[4]	Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.
[5]	Akesbi M. Dissertation)., La Pratique de La Médecine Alternative et Complémentaires Chez Les Herboristes a La Région de Fès (Doctoral).; 2021.
[6]	Liu Z, Gong J, Huang W, Lu F, Dong H. The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review. Evidence-based Complement Altern Med. 2021.
[7]	Yessoufou A, Gbenou J, Grissa O, et al. Anti-hyperglycemic effects of three medicinal plants in diabetic pregnancy: Modulation of T cell proliferation. BMC Complement Altern Med. 2013;13.
[8]	Assou C, Anago E, Senou M, et al. Anti-hyperglycemic effect of Momordica charantia green fruit extract. Int J Pharm Sci Invent. 2022;11(5):6-16.
[9]	Senou M, Khalifa C, Thimmesch M, et al. A coherent organization of differentiation proteins is required to maintain an appropriate thyroid function in the pendred thyroid. J Clin Endocrinol Metab. 2010;95(8):4021-4030.
[10]	I. Ahmed, M.S. Lakhani, M. Gillett, A. John HR. Hypotriglyceridemic and hypocholesterolemic effects of anti- diabetic Momordica charantia ( karela ) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract. 2000:155–161.
[11]	Aljohi A, Matou-Nasri S, Ahmed N. Antiglycation and antioxidant properties of Momordica charantia. PLoS One. 2016;11(8):1-14.
[12]	Fachinan R, Yessoufou A, Nekoua MP, Moutairou K. Effectiveness of Antihyperglycemic Effect of Momordica charantia: Implication of T-Cell Cytokines. Evidence-based Complement Altern Med. 2017;2017:1-9.
[13]	Gurav, A., Mondal, D. B., & Vijayakumar H. . In vitro qualitative and quantitative phytochemical analysis of ethanolic and 50% ethanolic extracts of Tinospora cordifolia, Momordica charantia, Cucurbita maxima and Raphanus sativus. In: ; 2014:4-6.
[14]	Samba B, Cyrille AN, Niane K, Ndiaye B, Cisse M, Diop CM. Impact of Extraction on Biochemical Properties and Antioxidant Potential of Momordica charantia L . Seeds ’ Oil. 2022:147-164.
[15]	Chaturvedi, P., George, S., Milinganyo, M., & Tripathi YB. Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2004:18(11), 954-956.
[16]	Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract. 1998;40(3):145-151.
[17]	Hardt, P. D., Killinger, A., Nalop, J., Schnell-Kretschmer, H., Zekorn, T., & Klör HU. Chronic pancreatitis and diabetes mellitus: a retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. ,. Pancreatology. 2002;2(1), 30-3.
[18]	Poitout, V., & Robertson RP. Minireview: secondary β-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity. Endocrinology. 2002:143(2), 339-342.
[19]	Nivitabishekam, S. N., Asad, M., & Prasad VS. Pharmacodynamic interaction of Momordica charantia with rosiglitazone in rats. Chem Biol Interact. 2009;177(3), 24.
[20]	Baynes, J. W., & Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. . Diabetes. 1999;48(1), 1-9.
[21]	Cemek, M., Kağa, S., Şimşek, N., Büyükokuroğlu, M. E., & Konuk M. Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats. J Nat Med. 2008:62, 284-293.
[22]	Grover, J. K., & Yadav SP. Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol. 2004:93(1), 123-132.
[23]	Wu, S. J., & Ng LT. Antioxidant and free radical scavenging activities of wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) in Taiwan. LWT-Food Sci Technol. 2008:41(2), 323-330.